Blood Cancers Today November 2023

November 2023

This issue of Blood Cancers Today includes a feature on artificial intelligence in blood cancers; a Get to Know with Sarah Tasian, MD; an editorial by Guillermo Garcia-Manero; and more.

Viewpoints

Associate Editor's Message

Is ‘Inflamodulation’ What’s Missing From AML Immunotherapy?

Editorial

Questions on the Treatment of Patients with Lower-Risk MDS

Features

Get to Know

Get to Know... Sarah Tasian, MD

In Focus

When Will AI Be Ready for Prime Time in Blood Cancers?

News

Regulatory Actions

FDA Approves Bosutinib for Chronic Phase Ph-Positive CML in Pediatric Patients

EMA Committee Recommends Approval of Zanubrutinib for Follicular Lymphoma

Fatal Reaction in Lacutamab Clinical Trial Leads to FDA Partial Hold

EC Grants Conditional Marketing Authorization to Epcoritamab for Relapsed, Refractory DLBCL

FDA Approves Ivosidenib Treatment for Relapsed or Refractory MDS

Meeting News

COMMANDS Biomarker Analysis Explores Luspatercept Mechanism in LR-MDS

Is Outpatient Administration of Liso-Cel Cost Efficient for Patients with CLL?

Study Finds High Economic Burden in Patients with MPNs

Enrollment Underway for Phase II Study of Oral HMA Plus Magrolimab in MDS

How Prevalent Are Financial, Time Toxicity in Patients with Multiple Myeloma?

What Are the Real-world Outcomes in Multiple Myeloma After Triple-Class Exposure?

Editorial Board

Sagar Lonial, MD, FACPEditor-in-Chief | Chief Medical Officer of Winship Cancer Institute at Emory University School of Medicine

Guillermo Garcia-Manero, MDAssociate Editor | Chief, Section of Myelodysplastic Syndromes, The University of Texas MD Anderson Cancer Center

Kami Maddocks, MDAssociate Editor | Professor of Clinical Internal Medicine in the Division of Hematology at The Ohio State University

Elias Jabbour, MDExecutive Editor | DB Lane Cancer Research Fund Distinguished Professor in Leukemia Research, MD Anderson Cancer Center

Thomas Martin, MDAssociate Editor | Clinical Research Director, UCSF Helen Diller Family Comprehensive Cancer Center

Jerald Radich, MDAssociate Editor | Professor in the Clinical Research Division and Kurt Enslein Endowed Chair at Fred Hutch

Laurie Sehn, MD, MPHAssociate Editor | Clinical Professor of Medical Oncology, British Columbia Cancer Centre for Lymphoid Cancer